---
category: news
title: "Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid"
excerpt: "Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability with the signing of an agreement to acquire Vienna-based Dedicaid GmbH (Dedicaid),"
publishedDateTime: 2023-04-27T00:45:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-1032265571"
webUrl: "https://markets.businessinsider.com/news/stocks/telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-1032265571"
type: article
quality: 50
heat: 70
published: true

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

related:
  - title: "Australian biopharma Telix banks on AI with Dedicaid acquisition"
    excerpt: "Telix is expanding its AI capability with the acquisition of Austria-based Dedicaid, a spin-off of the Medical University Vienna."
    publishedDateTime: 2023-04-27T11:08:00Z
    webUrl: "https://www.labiotech.eu/trends-news/telix-acquires-ai-company-dedicaid/"
    type: article
    provider:
      name: labiotech
      domain: labiotech.eu
    quality: 39
    images:
      - url: "https://www.labiotech.eu/wp-content/uploads/2023/04/shutterstock-1044933463.jpg"
        width: 1024
        height: 384
        isCached: true
  - title: "Telix Pharmaceuticals Limited: Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid"
    excerpt: "Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability"
    publishedDateTime: 2023-04-26T23:35:00Z
    webUrl: "https://www.finanznachrichten.de/nachrichten-2023-04/58924274-telix-pharmaceuticals-limited-telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-008.htm"
    type: article
    provider:
      name: Finanznachrichten
      domain: finanznachrichten.de
    quality: 6

secured: "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;X3GKABAhzQLQpqDa4jlwLQ=="
---

